{"id":"W4413774531","doi":"10.1016/s2152-2650(25)01319-9","title":"POSTER: MM-1049 DREAMM-7 Study of BelantamabMafodotin + Bortezomib + Dexamethasone vs Daratumumab + Bortezomib + Dexamethasone in Relapsed/Refractory Multiple Myeloma: Efficacy in Patients by Subsequent Therapy","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Daratumumab; Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Refractory (planetary science); Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001998726,0.001546216,0.003786664,0.0004812165,0.0006204383,0.001393303,0.001321661,0.001716218,0.01221435],"category_scores_gemma":[0.001334034,0.0006838005,0.00380528,0.0003634031,0.0009945281,0.001071914,0.0006429912,0.004953814,0.002441889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001249512,"about_ca_system_score_gemma":0.00212736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00156829,"about_ca_topic_score_gemma":0.002688559,"domain_scores_codex":[0.9991003,0.0004246672,0.00006262676,0.0001445315,0.00008087858,0.000186949],"domain_scores_gemma":[0.9989927,0.000217965,0.0001336779,0.0000878494,0.00005898442,0.0005087688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9595937,0.009336697,0.0009525619,0.0002644444,0.00130425,0.00003926576,0.00004192961,0.0004451465,0.002622433,0.000132996,0.001919102,0.0233474],"study_design_scores_gemma":[0.6854469,0.2986617,0.008691479,0.00008346164,0.001569297,0.00007631747,0.00004052881,0.0005458077,0.001404759,0.0002272031,0.003209027,0.00004348152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752946,0.009283,0.0004532502,0.001959821,0.001645441,0.001854864,0.003742715,0.0001576084,0.005608719],"genre_scores_gemma":[0.9709981,0.004842733,0.001402769,0.002762176,0.001522578,0.001805756,0.004651421,0.00007734098,0.01193716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01221435,"threshold_uncertainty_score":0.04086113,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03154759248529704,"score_gpt":0.3419932738643108,"score_spread":0.3104456813790137,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}